Found: 23
Select item for more details and to access through your institution.
Reduced Expression of PDLIM4 Gene Correlates with Good Prognosis in Acute Myeloid Leukemia.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2013, v. 21, n. 5, p. 1111, doi. 10.7534/j.issn.1009-2137.2013.05.005
- By:
- Publication type:
- Article
Expression of RAGE-1 Gene in Acute Myeloid Leukemia.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2013, v. 21, n. 1, p. 20, doi. 10.7534/j.issn.1009-2137.2013.01.005
- By:
- Publication type:
- Article
Gene Expression of Helicase Antigen in Patients with Acute and Chronic Myeloid Leukema.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2011, v. 19, n. 5, p. 1171
- By:
- Publication type:
- Article
Quantification of Prame Gene Transcript in Chronic Myeloid Leukemia.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2010, v. 18, n. 4, p. 855
- By:
- Publication type:
- Article
Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0894-y
- By:
- Publication type:
- Article
Intragenic hypomethylation of <italic>DNMT3A</italic> in patients with myelodysplastic syndrome.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2018, v. 56, n. 3, p. 485, doi. 10.1515/cclm-2016-0142
- By:
- Publication type:
- Article
Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndrome.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 5, p. 865, doi. 10.1515/cclm-2015-0536
- By:
- Publication type:
- Article
Overexpression of lncRNA <em>PANDAR </em>predicts adverse prognosis in acute myeloid leukemia.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 4999, doi. 10.2147/CMAR.S180150
- By:
- Publication type:
- Article
Aberrant hypomethylation of DDX43 promoter in myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 2, p. 293, doi. 10.1111/j.1365-2141.2012.09138.x
- By:
- Publication type:
- Article
Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 9, p. 1853, doi. 10.1007/s00432-017-2429-z
- By:
- Publication type:
- Article
DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 14, p. 6393, doi. 10.1002/cam4.2540
- By:
- Publication type:
- Article
U2AF1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045760
- By:
- Publication type:
- Article
Overexpression of LncRNA ITGB2-AS1 Predicts Adverse Prognosis in Acute Myeloid Leukemia.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2021, v. 29, n. 5, p. 1436, doi. 10.19746/j.cnki.issn1009-2137.2021.05.011
- By:
- Publication type:
- Article
Detection of the JAK2 mutation in myeloproliferative neoplasms by asymmetric PCR with unlabeled probe and high-resolution melt analysis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
CEBPA methylation and mutation in myelodysplastic syndrome.
- Published in:
- Medical Oncology, 2015, v. 32, n. 7, p. 1, doi. 10.1007/s12032-015-0605-z
- By:
- Publication type:
- Article
Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia.
- Published in:
- Medical Oncology, 2015, v. 32, n. 1, p. 1, doi. 10.1007/s12032-014-0386-9
- By:
- Publication type:
- Article
Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0165948
- By:
- Publication type:
- Article
Dysregulation of LINC00324 associated with methylation facilitates leukemogenesis in de novo acute myeloid leukemia.
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 3, p. 567, doi. 10.1111/ijlh.13809
- By:
- Publication type:
- Article
Methylation‐independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 6, p. 4707, doi. 10.1002/jcp.26253
- By:
- Publication type:
- Article
IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- 2012
- By:
- Publication type:
- journal article
IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 4, p. 519, doi. 10.1007/s00277-011-1352-7
- By:
- Publication type:
- Article
Hypomethylation of MIR‐378 5'‐flanking region predicts poor survival in young patients with myelodysplastic syndrome.
- Published in:
- Molecular Genetics & Genomic Medicine, 2020, v. 8, n. 1, p. N.PAG, doi. 10.1002/mgg3.1067
- By:
- Publication type:
- Article